Journal articleAnn Surg2014
A single-arm, nonrandomized phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinoma.
- Journal
- Ann Surg
- Published
- 1 July 2014
- Citations
- 103
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Trials 3
- Builds on itGemcitabine and Oxaliplatin in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery NCT00536874↗
- BackgroundA Study of Administering FOLFIRINOX Before Surgery For Potentially Curable Pancreatic Cancer NCT03167112↗
- BackgroundNeoadjuvant Modified FOLFIRINOX in Borderline Resectable Pancreatic Cancer NCT02749136↗